Name: UMIN ID:
Unique ID issued by UMIN | UMIN000026965 |
---|---|
Receipt number | R000030887 |
Scientific Title | Phase II clinical trial of WT1 peptide-based vaccine combined with Temozoromide for patients with glioblastoma. |
Date of disclosure of the study information | 2017/04/12 |
Last modified on | 2019/04/15 13:36:39 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/04/12 17:25:44 | ||
2 | Update | 2017/10/12 09:58:57 | Recruitment status |
|
3 | Update | 2019/04/15 13:32:46 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Email3 Organization Organization Address Address Tel |
|
4 | Update | 2019/04/15 13:36:39 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |